HZNP News 13.37 Horizon Pharma Inc (HZNP)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 18, 2014 at 5:39 AM

Horizon Pharma Inc (HZNP) 13.37 $HZNP

Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors
Marketwire - Thu Apr 17, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors. Additionally, Jean-Francois Formela, M.D. has resigned from the Horizon board of directors.

Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd.
Marketwire - Wed Apr 16, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that it has received notice of the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, in connection with its proposed acquisition of Vidara Therapeutics International Ltd. ("Vidara"

. The waiting period was scheduled to expire on May 1, 2014. Completion of the transaction remains subject to approval by Horizon's stockholders and other customary closing conditions.

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Horizon Pharma announces Notice of Allowance for US Patent Application for RAYOS for treating a broad range of diseases
M2 - Fri Apr 11, 4:56AM CDT
Specialist pharmaceutical company Horizon Pharma (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers its US approved product RAYOS.

Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:33AM CDT
Horizon Pharma looks well positioned for a solid gain, but has been overlooked by investors lately. This Generic Drugs stock has actually seen estimates rise over the past month for the current fiscal year. This year’s expected earnings growth over the prior year is 147.1%, which should ultimately translate into price appreciation.

Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
Marketwire - Thu Apr 10, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers the Company's U.S. approved product RAYOS(R).

Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 03, 12:47PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma
PR Newswire - Wed Apr 02, 8:59AM CDT
On Tuesday, April 01, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. The session saw a positive impact from Consumer Discretionary, Information Technology and Industrials sectors along with a drag from Utilities, and Consumer Staples sectors. A number of stocks saw large movements, including JinkoSolar Holding Co. Ltd (NYSE: JKS), Horizon Pharma Inc. (NASDAQ: HZNP), YY Inc. (NASDAQ: YY) and Questcor Pharmaceuticals Inc. (NASDAQ: QCOR). Free technical research on JKS, HZNP, YY and QCOR can be downloaded upon signing up at:

Biotechs Giving Uncle Sam the Shaft
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 31, 5:08PM CDT
As they say in real estate: location, location, location. Biotechs have been acquiring companies in large part for their address. Specifically, they're buying so they can move to places like Ireland, where taxes are substantially lower than in the...

Horizon Pharma grants inducement stock options to 26 new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Mar 28, 4:55AM CDT
Pharmaceutical company Horizon Pharma (NasdaqGS:HZNP) said on Thursday that it has awarded inducement stock options to purchase an aggregate of 96,750 shares of its common stock to 26 new employees.

Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Thu Mar 27, 9:20PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on March 27, 2014 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 96,750 shares of common stock to 26 new employees.

Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:47AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on HZNP’s earnings for the coming quarter and year.

Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Boston Scientific Corporation (NYSE: BSX), Horizon Pharma Inc. (NASDAQ: HZNP), Alkermes Plc (NASDAQ: ALKS), Agilent Technologies Inc. (NYSE: A), and Becton, Dickinson and Co. (NYSE: BDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews

Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 8:18AM CDT
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)?

Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference
Marketwire - Tue Mar 25, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, its chairman, president and chief executive officer, will present at the 21st Annual Future Leaders in the Biotech Industry Conference on Friday, March 28, 2014 at 3:30 p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of Horizon and its corporate activities.

Roundtable Top Picks for the Week of Mar. 24th - Video Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 3:52PM CDT
Ideas for Auto Parts, Financials and Pharmaceuticals. Opportunities covered include Motorcar Parts of America, Inc. (MPAA), Financial Select Sector SPDR Fund (XLF) and Horizon Pharmaceutical (HZNP).

3 Stocks Rising on Unusual Volume
at The Street - Mon Mar 24, 7:50AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Horizon Pharma to Host Corporate Update Meeting on March 27, 2014
Marketwire - Mon Mar 24, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) will host a Corporate Update Meeting on Thursday, March 27, 2014 at 7:30 a.m. Eastern Time in New York, NY.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Canadian Solar Gears Up for Q3 2026 Earnings Call

Canadian Solar Prepares for Earnings Disclosure Well, strap in, folks. Canadian Solar Inc. (NASDAQ: CSIQ)—a staple in the solar arena—announced that they'll unveil their third quarter 2026 financials on December 3. It's going to be a call worth dialing into. They're holding it right at 8:00 a.m. Eastern Time. You can pop over to their website for a live webcast or go...

SEMIFIVE Soars on Record-Breaking Order Spike

By Henry Turner Updated Nov 13, 2026 Category News Views 131

SEMIFIVE's Order Surge: An Investor's Triumph Throw the confetti and pop the champagne, SEMIFIVE just shellacked its previous records with a blistering 437% year-over-year increase in new orders for the third quarter of 2026. We're talking a leap from KRW 33.2 billion last year to a staggering KRW 178.4 billion this time around. These aren't just numbers on a spreadsheet;...

HSBC Capital Move: Tender Offer Satisfaction Explained

HSBC's Capital Reshuffle: What's Gotten Sorted? If you've been eyeballing HSBC Holdings, you know they're putting some serious skin in the game. They've just wrapped up a hefty $1.5 billion tender offer for their perpetual securities, checking off a big condition known as the New Issue Condition. Diving Into the Details of the Offer Let's break this down like you're...

Missoula Inventor Offers Handy Phone Solution on the Move

Adjustable Convenience for the Modern Commuter When you're commuting or just lounging around, less hand strain and more comfort sounds like a no-brainer, right? Well, an inventive soul from Missoula, Montana, just might have cracked this little nut with a gizmo they're calling the COMMUTER PHONE. Imagine never having to juggle your phone during those bumpy moments on the...

MyStation Disrupts Media Ownership, Empowers Creators

Changing the Game for Content Creators Never thought you'd see the day where you're not bowing down to broadcast giants? Well, here it is. MyStation's stepping into the ring, swinging hard at traditional media's big wigs, handing over the reins to anyone daring enough to build an audience. This launch can dish out a thrashing to those high walls keeping folks from owning...

Compass, Inc. Faces Class Action After Merger Fallout

Compass Merger Sparks Lawsuit Slammed with a class action, Compass, Inc. (NYSE: COMP) finds itself tangled in a mess. Earlier this year, things were looking up for Compass when they merged with Anywhere Real Estate Inc., but it seemed like a beautiful day in the neighborhood until some dark clouds appeared. This whole debacle went down thanks to allegedly misleading...

Backdoor Reference Checks: A Hiring Minefield?

What's Really Happening with Job References? Every job seeker has been there, right? You're all set, resume polished to a shine, references lined up like a choir ready to sing your praises, and then bam—you hear that employers are contacting folks you never listed. A new report from Zety highlights this eyebrow-raising trend, and it's got us all questioning the value...

Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

SPOC Energy's Hiring Push Signals Growth Surge

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...